Common questions about Levoreact Oftalmico (FAQ)
Q: Are there any serious side effects I should be aware of?
Official product information notes that Hypersensitivity (a severe allergic reaction) to levocabastine or any ingredient is a contraindication to its use. While the medicine is applied to the eye, uncommon systemic effects such as somnolence (drowsiness), nausea, and fatigue have been reported. Serious adverse reactions are defined in regulatory documents as those that may be considered life-threatening or require clinical attention.
Q: Does Levoreact Oftalmico contain preservatives?
Yes, official regulatory documents confirm that the formulation contains the preservative benzalkonium chloride. Regulatory documents list special precautions for patients who wear soft contact lenses due to the presence of the preservative, which may be absorbed by the lens material.
Q: What is the age limit for using Levoreact Oftalmico?
Official guidance indicates the medicine is generally applicable for children 6 years of age and over in many countries. However, safety and effectiveness information may state that use has not been established for children under 12, or for patients over the age of 65.
Q: Is it okay to drive after using the eye drops?
Regulatory documents state that the medicine is generally not expected to interfere with the ability to drive or operate machinery. However, since uncommon side effects like drowsiness (somnolence) and blurred vision can occur, the product labeling states that caution is appropriate if those symptoms develop.
Q: Do I need a prescription for Levoreact Oftalmico?
The product is typically classified as a prescription medicine in many regions, meaning it requires authorization from a healthcare professional. This classification differentiates it from drugs that are generally available over-the-counter.
Q: What is the difference between a suspension and a solution?
Levoreact Oftalmico is an ophthalmic suspension, meaning the active ingredient is finely dispersed, but not completely dissolved, in the liquid. As a suspension, the bottle's design requires preparation before application to ensure the concentration is uniform. A solution, in contrast, is a clear liquid where the medicine is fully dissolved.
Q: Are there different strengths available for Levoreact Oftalmico?
The official product information consistently lists the standard concentration available as the 0.05% levocabastine hydrochloride ophthalmic suspension.
Q: Does using Levoreact Oftalmico require any special precautions?
Precautions documented in the official labeling include: preparing the suspension before use, maintaining the sterility of the dropper tip, and the mandatory removal of soft contact lenses before application, with a minimum waiting period before re-insertion.
Q: Can Levoreact Oftalmico be used for long-term relief?
Published research has evaluated the drug for continuous use in open-label extension studies for periods up to one year. Official research notes that evidence regarding the long-term impact beyond two years remains limited.
Q: How long does the effect of one drop last?
Studies, such as those involving antigen challenges, have indicated that the anti-allergic activity of the medicine was maintained for at least two hours following its instillation into the eye.
Q: What should I do if the bottle gets cloudy?
Regulatory guidelines advise that the product be discarded if the suspension has discolored. Discoloration suggests the product’s quality may be compromised, and the official instructions advise against using it in that state.
Q: Can Levoreact Oftalmico be used for redness caused by wind or dust?
The product is officially indicated for the treatment of ocular symptoms associated with allergic conjunctivitis. Its use for non-allergic causes of irritation or redness, such as wind or dust exposure, is not a specified indication in official documents.
Q: Is it normal to feel a dryness sensation after the drops?
Official adverse reaction reports for this medication list eye dryness as a potential, less common side effect. The most frequently reported local effects are mild stinging or burning at the site of application.
Q: Does the medicine contain steroids?
No. The active ingredient in Levoreact Oftalmico is levocabastine hydrochloride, which belongs to the class of antihistamines. Steroid compounds are not listed in the standard formulation of this product.
Q: Is it okay if I don't feel anything after using the drops?
The drug’s action is based on histamine-blocking, a process that is not physically felt. While some users report common side effects like stinging, the absence of a sensation does not necessarily imply the intended action is absent.
Q: Is it common for people to be allergic to the inactive ingredients?
Official labeling states that Hypersensitivity is a contraindication to any component of the product, which includes the active ingredient, the preservative, and all other inactive ingredients. Specific data on the commonality of allergies to inactive ingredients is generally not published in product labeling.
Q: What happens if I accidentally put too many drops in my eye?
Official guidance indicates that if more than the specified amount is applied to the eye, contact with a doctor or pharmacist is appropriate. If the medicine were accidentally swallowed orally, drinking plenty of fluids is generally advised.
